001438039 000__ 05731cam\a2200613\i\4500
001438039 001__ 1438039
001438039 003__ OCoLC
001438039 005__ 20230309004245.0
001438039 006__ m\\\\\o\\d\\\\\\\\
001438039 007__ cr\un\nnnunnun
001438039 008__ 210713s2021\\\\sz\a\\\\ob\\\\000\0\eng\d
001438039 019__ $$a1260347846$$a1266809116$$a1268574543
001438039 020__ $$a9783030688585$$q(electronic bk.)
001438039 020__ $$a3030688585$$q(electronic bk.)
001438039 020__ $$z9783030688578$$q(print)
001438039 020__ $$z3030688577$$q(print)
001438039 0247_ $$a10.1007/978-3-030-68858-5$$2doi
001438039 035__ $$aSP(OCoLC)1260132256
001438039 040__ $$aYDX$$beng$$erda$$epn$$cYDX$$dGW5XE$$dEBLCP$$dOCLCO$$dOCLCF$$dDCT$$dZ@L$$dDKU$$dUKAHL$$dN$T$$dOCLCO$$dCOM$$dOCLCQ$$dOCLCO$$dOCLCQ
001438039 049__ $$aISEA
001438039 050_4 $$aRC270.3.T65
001438039 08204 $$a616.99/40757$$223
001438039 24500 $$aAtlas of clinical PET-CT in treatment response evaluation in oncology /$$cStefano Fanti, Gopinath Gnanasegaran, Ignasi Carrió, editors.
001438039 264_1 $$aCham :$$bSpringer,$$c[2021]
001438039 300__ $$a1 online resource (xiii, 488 pages) :$$billustrations
001438039 336__ $$atext$$btxt$$2rdacontent
001438039 337__ $$acomputer$$bc$$2rdamedia
001438039 338__ $$aonline resource$$bcr$$2rdacarrier
001438039 347__ $$atext file
001438039 347__ $$bPDF
001438039 504__ $$aIncludes bibliographical references.
001438039 5050_ $$aPart I. Therapy response evaluation: science and practice. Treatment response evaluation: science and practice -- CT in treatment response assessment in oncology -- MRI and Diffusion-Weighted MRI in Treatment Response Evaluation Overview -- PET and PET-CT in treatment response evaluation: overview -- Conventional radiological techniques and PET-CT in treatment response evaluation in postsurgical setting -- Conventional radiological and PET-CT assessment of treatment response evaluation in chemotherapy setting -- Conventional radiological techniques and PET-CT in treatment response evaluation in post-radiotherapy setting -- Conventional radiological techniques and PET-CT in treatment response evaluation in immunotherapy settings -- Treatment response evaluation of bone metastases using 18F-NaF -- Reporting post-therapy scans -- Part II. Therapy response evaluation: clinical atlas. 18F-FDG PET/CT in treatment response evaluation in head and neck cancer -- PET/CT in treatment response evaluation: lung cancer -- 18F-FDG PET/CT and Non 18 F-FDG-PET/CT in treatment response evaluation in neuro-oncology -- PET/CT in the assessment of treatment response in hepatobiliary, gall bladder and pancreatic malignancies -- 18F-FDG PET/CT in treatment response evaluation: gastroesophageal cancer -- PET-CT in treatment response evaluation in lymphoma -- 18F-FDG PET/CT in treatment response evaluation: breast cancer -- 18F-Choline, 68Ga-PSMA-11 and 18F-FDG PET/CT in treatment response evaluation: prostate cancer -- FDG PET/CT in treatment response evaluation of gynecological malignancies -- [18 F]FDG PET/CT in treatment response evaluation: colorectal cancer -- 18F-FDG PET in treatment response evaluation: soft tissue sarcomas -- 18F-FDG PET-CT in treatment response evaluation in cutaneous malignant melanoma -- 18F-FDG PET-CT in treatment response evaluation: multiple myeloma -- 18F-FDG PET-CT and 18 F-NaF in treatment response evaluation: bone metastases and bone tumours -- FDG-PET/CT in assessment of treatment response in pediatric lymphoma -- 18 F-FDG PET/CT in treatment response evaluation in thyroid cancer -- 68Ga-DOTA PET-CT in treatment response evaluation: neuroendocrine tumours -- 18F-FDOPA PET/CT for treatment response assessment -- 18F-FLT/FET PET-CT in treatment response evaluation.
001438039 506__ $$aAccess limited to authorized users.
001438039 520__ $$a"This atlas is a superb guide to the use of PET-CT for the evaluation of treatment response in oncology patients based on its ability to assess tumor metabolic status. The first part of the book explains the role of PET-CT in response evaluation in different treatment settings. For comparison, overviews of the value and limitations of CT alone, PET alone, and anatomical and functional MRI are included. Guidance is also provided on the reporting of PET-CT scans in post-therapy scenarios. The second part of the book describes and illustrates the use of PET-CT with FDG and other tracers to assess the treatment response of malignancies at different anatomic sites. Featuring a wealth of images, informative case-based discussion, and evidence-based teaching points, these disease-specific chapters clearly demonstrate the key role that PET-CT can play in distinguishing early responders from patients who are non-responders or are resistant to treatment. Prompt and accurate evaluation of treatment response is vital as we enter the era of individualized medicine, and this atlas will persuade readers of the considerable advantages of PET-CT over conventional radiological and clinical methods."--Publisher's description
001438039 588__ $$aResource, viewed October 4, 2021.
001438039 650_0 $$aCancer$$xTomography$$vAtlases.
001438039 650_0 $$aTomography, Emission$$vAtlases.
001438039 650_6 $$aCancer$$xTomographie$$vAtlas.
001438039 650_6 $$aTomographie par émission$$vAtlas.
001438039 655_7 $$aatlases.$$2aat
001438039 655_7 $$aAtlases.$$2lcgft
001438039 655_7 $$aAtlas.$$2rvmgf
001438039 655_0 $$aElectronic books.
001438039 7001_ $$aFanti, Stefano,$$eeditor.
001438039 7001_ $$aGnanasegaran, Gopinath,$$eeditor.
001438039 7001_ $$aCarrió, Ignasi,$$eeditor.
001438039 77608 $$iPrint version:$$z9783030688578$$w(OCoLC)1230231915
001438039 77608 $$iPrint version:$$z3030688577$$z9783030688578$$w(OCoLC)1230231915
001438039 852__ $$bebk
001438039 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-030-68858-5$$zOnline Access$$91397441.1
001438039 909CO $$ooai:library.usi.edu:1438039$$pGLOBAL_SET
001438039 980__ $$aBIB
001438039 980__ $$aEBOOK
001438039 982__ $$aEbook
001438039 983__ $$aOnline
001438039 994__ $$a92$$bISE